window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-EE4YC2THRT');

Newsletter #44 – June 2024

In this edition: Buprenorphine XL, provincial Youth Wellness Hubs, how empathy improves patient outcomes.

Newsletter #43 – May 2024

In this edition: Contigency Management in RAAM clinic, alcohol withdrawal in EDs, working towards sobriety, primary care crisis.

March Webinar slides: Considerations in the Care of People Who Use Simulants

META:PHI March webinar presented by Dr. Tany Hauck and Stephanie Rochon

Newsletter #42 – April 2024

In this edition: interprofessional collaboration, Hep C mobile care and more

Newsletter #41 – March 2024

In this edition: Auto micro-induction of buprenorphine XL, relationship-building as crucial as methadone, unique opioid stewardship program, and musings on the meaning of harm reduction.

Newsletter #40 – February 2024

In this edition: Thoughts from a semi-retired addiction doctor; mobile crisis intervention program; shocking stats on OAT initiation after ED visits; one journey of addiction and recovery.

New year, new resources: Slow-release oral morphine recommendations, OAT decision aid tool, and ED toolkit for alcohol-related presentations

Happy new year!

META:PHI is very excited to announce the release of several new resources:

All of these documents can be downloaded from our Resource Library.

New resources: A new framework for methadone carries

We have recently produced a set of documents outlining a new framework for making decisions about take-home doses of methadone:

All of these documents can be downloaded from our Resource Library.

Information for people on methadone and health care providers about new generic methadone products

Two new generic methadone products have been added to the Ontario provincial formulary. As of September 29th, only the equivalent cost of generic methadone will be reimbursed by the province. META:PHI undertook a consultation process to produce information sheets on this change for people on methadone and for health care providers.

Many thanks to the individuals who contributed to these documents:

Jennifer Brasch, Lisa Bromley, Chris Cavacuiti, Katie Dunham, Laura Jones,  Robyn Kalda, Suzanne Latreille, Andrew McLeod, Charlotte Munro, Rebecca Penn, Lori Regenstreif, Cassandra Schuck, Elizabeth Shouldice, Ashley Smoke, Lorilee Steadman, Jasen Szabo, Maria Zhang

Take-home Naloxone Program in EDs and Hospitals

These materials are intended for EDs and hospitals who want to set up their own take-home naloxone programs, in collaboration with the Ontario Naloxone Program and local public health units.

Steps for building a take-home naloxone program in the ED

ED Primer for take-home naloxone

Pamphlet – 5 Steps to Save a Life